Pretax income is the income that a company earns before paying income taxes. Amneal Pharmaceuticals's pretax income for the
three
months ended in Dec. 2023 was $-83 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-40 Mil.
Amneal Pharmaceuticals's pretax margin was -13.53%.
During the past 8 years, Amneal Pharmaceuticals's highest Pretax Margin was 21.10%. The lowest was -13.54%. And the median was -1.74%.
Amneal Pharmaceuticals Pre-Tax Income Historical Data
The historical data trend for Amneal Pharmaceuticals's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Amneal Pharmaceuticals's Pre-Tax Income
For the Drug Manufacturers - Specialty & Generic subindustry, Amneal Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amneal Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amneal Pharmaceuticals's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Amneal Pharmaceuticals's Pre-Tax Income falls into.
Amneal Pharmaceuticals Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Amneal Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-40 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amneal Pharmaceuticals (NAS:AMRX) Pre-Tax Income Explanation
Amneal Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 8 years, Amneal Pharmaceuticals's highest Pretax Margin was 21.10%. The lowest was -13.54%. And the median was -1.74%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amneal Pharmaceuticals Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Amneal Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Amneal Pharmaceuticals (Amneal Pharmaceuticals) Business Description
Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMRX has been successfully added to your 